Patent details

EP1345591 Title: PHARMACEUTICAL AEROSOL FORMULATION

Basic Information

Publication number:
EP1345591
PCT Application Number:
PCT/SE/2001/002853
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP012712139
PCT Publication Number:
WO/2002/049616
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL AEROSOL FORMULATION
French Title of Invention:
PREPARATION PHARMACEUTIQUE EN AEROSOL
German Title of Invention:
PHARMAZEUTISCHE AEROSOLFORMULIERUNG
SPC Number:

Dates

Filing date:
19/12/2001
Grant date:
02/03/2005
EP Publication Date:
02/03/2005
PCT Publication Date:
27/06/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/09/2003
EP B1 Publication Date:
02/03/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/12/2005
Expiration date:
19/12/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/12/2001
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:
BUCKTON Graham University of London
Address:
United Kingdom (GB)

2

Name:
GROSVENOR Martin
Address:
United Kingdom (GB)

3

Name:
WIKELEY Philip Fine Agrochemicals
Address:
United Kingdom (GB)

4

Name:
COLUMBANO Angela
Address:
United Kingdom (GB)

Priority

Priority Number:
0004750
Priority Date:
19/12/2000
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
A61K 9/12;
Filing date Document type Number of pages